Your browser doesn't support javascript.
loading
Incorporating Efficacy Data from Initial Trials Into Subsequent Evaluations: Application to Vaccines Against Respiratory Syncytial Virus.
Warren, Joshua L; Sundaram, Maria; Pitzer, Virginia E; Omer, Saad B; Weinberger, Daniel M.
Affiliation
  • Warren JL; From the Department of Biostatistics, Yale School of Public Health, New Haven, CT.
  • Sundaram M; Marshfield Clinic Research Institute, Center for Clinical Epidemiology & Population Health, Marshfield, WI.
  • Pitzer VE; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT.
  • Omer SB; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT.
  • Weinberger DM; Yale Institute of Global Health, New Haven, CT.
Epidemiology ; 35(2): 130-136, 2024 Mar 01.
Article in En | MEDLINE | ID: mdl-37963353
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Respiratory Syncytial Viruses / Vaccines Limits: Humans Language: En Journal: Epidemiology Journal subject: EPIDEMIOLOGIA Year: 2024 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Respiratory Syncytial Viruses / Vaccines Limits: Humans Language: En Journal: Epidemiology Journal subject: EPIDEMIOLOGIA Year: 2024 Document type: Article Country of publication: